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Abstract: Withania somnifera (ashwagandha) root extract is very popular ancient herbal medicine. The objective of the 
study was to characterize and evaluate the impact of The Trivedi Effect
®
-Biofield Energy Healing
 
Treatment (Energy of 
Consciousness) on phytoconstituents present in the ashwagandha root extract using LC-MS. Ashwagandha root extract was 
divided into two parts. One part was denoted as the control, while the other part was defined as The Trivedi Effect
®
 - Biofield 
Energy Treated sample, which received Energy of Consciousness Healing Treatment remotely from eighteen renowned 
Biofield Energy Healers. The LC-MS analysis of the control and treated samples showed a very close retention time (Rt), 
indicated that the polarity of the phytoconstituents present in the root extract are same. The numbers of peaks observed in the 
total ion chromatograms were 28 and 29 in the control and treated samples, respectively. The change in the peak height% of 
the phytoconstituents in the treated sample was altered significantly within the range of -50.91% to 118.12% compared with 
the control sample. Similarly, the change in the peak area% of most of the phytoconstituents in the treated ashwagandha was 
significantly altered within the range of -54.95% to 66.95% compared with the control sample. An additional peak was 
appeared in the treated sample at Rt of 5.72 minutes, which was not found in the control sample. The LC-MS spectra indicated 
the presence of possible withanolides like β-hydroxy-2,3-dihydro-withanolide F, withanolide A, withaferine A, withanone, 
withanolide D, ixocarpalactone A, withanolide S, thiowithanolide, etc. in both the samples. The peak are percentage (%) was 
altered in the identified withanolides, but withanolide sulfoxide was increased significantly by 12.44% in the treated sample 
compared with the control sample. These results indicated that The Trivedi Effect
®
 - Biofield Energy Treatment might have an 
impact on the intrinsic physicochemical properties of the phytoconstituents present in the ashwagandha root extract. This could 
be the probable cause of alteration in the peak height, peak area, and appearance of a new peak in the treated sample. As a 
result, the concentrations of the phytoconstituents altered in the treated sample compared with the control sample. The treated 
ashwagandha root extract would be helpful for designing better pharmaceutical/nutraceutical formulations which might be 
providing a better therapeutic response against autoimmune diseases, nervous and sexual disorders, infectious diseases, 
antiaging, diabetes, cancer, ulcer, immunological disorders, stress, arthritis, etc. 
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1. Introduction 
Now-a-days herbal medicines have been getting exploring 
throughout the world for the prevention and treatment of 
various diseases because of their impressive therapeutic 
effects and fewer side effects compared with the modern 
medicines [1]. The roots of Withania somnifera is an ancient 
Rasayana herb and is popularly known as ‘Ashwagandha’ or 
winter cherry or ‘Indian ginseng’ [2, 3]. W. somnifera is 
mostly used in the herbal drugs and nutraceuticals for the 
prevention and treatment of various diseases such as nervous 
and sexual disorders, infectious diseases, diabetes, cancer, 
ulcer, immunological disorders, stress, arthritis, etc. As a 
tonic, it is useful to arrest the aging process, rejuvenate the 
body and boost the defense system against infectious 
disorders as well as to promote the longevity [2-6]. The 
major active phytoconstituents of W. somnifera root extract 
contains highly oxygenated withanolides. Besides 
withanolides, ashwagandha root contains alkaloids, 
numerous withanamides, sitoindosides, starch, reducing 
sugars, peroxidases, glycosides, dilcitol, withanicil, benzoic 
acid phenyl acetic acid, benzyl alcohol, 2-phenyl 
ethanol,3,4,5-trihydroxy cinnamic acid, etc. [7-9]. Isolated 
withanolides from W. somnifera possess various 
pharmacological activities includes antioxidant, anticancer, 
immunomodulating, hepatoprotective, neuroprotective, anti-
inflammatory, antiarthritic, antimicrobial, hypoglycaemic, 
etc. [10-12]. Therefore, a new proprietary herbomineral 
formulation was formulated that consisted of the herbal 
ashwagandha root extract along with zinc, magnesium, and 
selenium minerals. This herbomineral formulation was 
designed as a nutraceutical supplement and can be used for 
the prevention and treatment of various human disorders. 
Every living organism preserves some kind of unique 
quality, an élan vital or vital force, which contributes the ‘life’. 
From the ancient-time, this living force is known as Prana by 
the Hindus, qi or chi by the Chinese, and ki by the Japanese 
and is usually believed to create the source of life that is 
related with soul, spirit, and mind. Now-a-days, this 
hypothetical vital force is considered as the Bioenergetics 
Field. This energy field is a dynamic electromagnetic field 
surrounding the human body. The Biofield Energy is infinite 
and paradimensional. It can freely flow between the human 
and the environment that leads to the continuous movement or 
matter of energy [13, 14]. Thus, the human can harness energy 
from the earth, the “universal energy field” and transmit it to 
any living or non-living object(s) around the globe. The 
objects always receive the energy and respond in a useful way. 
This process is known as Biofield Energy Healing Treatment 
[15-17]. Biofield (Putative Energy Fields) based Energy 
Therapies are used worldwide to promote health and healing 
[18]. The National Center of Complementary and Integrative 
Health (NCCIH) has been recognized and accepted Biofield 
Energy Healing as a Complementary and Alternative Medicine 
(CAM) health care approach in addition to other therapies, 
medicines and practices such as natural products, deep 
breathing, yoga, Tai Chi, Qi Gong, chiropractic/osteopathic 
manipulation, meditation, massage, special diets, homeopathy, 
progressive relaxation, guided imagery, acupressure, 
acupuncture, relaxation techniques, healing touch, movement 
therapy, hypnotherapy, pilates, rolfing structural integration, 
mindfulness, Ayurvedic medicine, traditional Chinese herbs 
and medicines, naturopathy, essential oils, aromatherapy, 
Reiki, cranial sacral therapy and applied prayer (as is common 
in all religions, like Christianity, Hinduism, Buddhism and 
Judaism) [19]. The Biofield Energy Treatment (The Trivedi 
Effect
®
) has been extensively studied with significant 
outcomes in many scientific fields such as cancer research 
[20], altered antimicrobial sensitivity of pathogenic microbes 
in microbiology [21-23], biotechnology [24, 25], genetics [26, 
27], changing the structure of the atom in relation to the 
various metals, ceramics, polymers and chemicals materials 
science [28-30], altered physical and chemical properties of 
pharmaceuticals [31, 32], nutraceuticals [33, 34], organic 
compounds [35-37], and improved overall growth and yield of 
plants in agricultural science [38, 39]. 
Modern, sophisticated techniques such as high-
performance liquid chromatography (HPLC) with photodiode 
array and evaporative light scattering detection, ultra-
performance liquid chromatography (UPLC) electrospray 
ionization (ESI) normally hyphenated with mass 
spectrometry is very useful for the metabolite profiling and 
identification of the crude herbal extract [8, 40-42]. The LC-
MS/MS, GC-MS and NMR analysis of W. somnifera root 
hydro-alcoholic extract revealed the presence of several 
known withanolides including withaferin A, withanolide D, 
withanoside IV or VI, withanolide sulfoxide, etc., along with 
two new withanolides i.e. dihydrowithanolide D and 
ixocarpalactone A [43]. Therefore, this study was designed 
for the characterization of the phytoconstituents present in 
the ashwagandha root hydro-alcoholic extract and to evaluate 
the influence of The Trivedi Effect
®
-Biofield Energy Healing 
on the phytoconstituents with the help of LC-MS. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Withania somnifera (ashwagandha) hydro-alcoholic root 
extract was purchased from Sanat Product Ltd., India. All the 
other chemicals used in this experiment were analytical grade 
procured from the local vendors. 
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2.2. Energy of Consciousness Treatment Strategy 
Ashwagandha root extract powder was one of the 
components of the new proprietary herbomineral 
formulation, developed by our research team, and it was 
used per se as the test sample for the current study. The test 
sample was divided into two parts, one part of the test 
sample was treated with The Trivedi Effect
®
 - Biofield 
Energy Treatment by renowned Biofield Energy Healers 
and defined as The Trivedi Effect
®
 treated sample, while 
the second part of the test sample did not receive any sort of 
treatment and defined as untreated or control ashwagandha 
root extract sample. The group of eighteen Biofield Energy 
Healers who participated in this study performed The 
Trivedi Effect
®
 treatment remotely to the test sample. 
Eleven of the Biofield Energy Healers were located in the 
U.S.A., four in Canada, one in Ireland, one in the United 
Kingdom, and one in Russia performed The Trivedi Effect
®
 
- Biofield Energy Treatment on the test sample that was 
located in the research laboratory of GVK Biosciences Pvt. 
Ltd., Hyderabad, India. This treatment was provided for 5 
minutes through Healer’s Unique Energy Transmission 
process remotely to the test sample under the laboratory 
conditions. None of the Biofield Energy Healers in this 
study visited the laboratory in person, nor had any contact 
with the sample. Similarly, the control sample was 
subjected to “sham” healers for 5 minutes, under the same 
laboratory conditions. The sham healer did not have any 
knowledge about The Trivedi Effect
®
 - Biofield Energy 
Treatment. After that, the treated and untreated samples 
were kept in similar sealed conditions and characterized 
thoroughly by LC-MS. 
2.3. Method of Liquid Chromatography-Mass Spectrometry 
(LC-MS) Analysis 
The LC-MS analysis of the control and treated samples 
were conducted by following the almost same method as 
mentioned in the recent literature [43] using The Waters
®
 
ACQUITY UPLC, Milford, MA, USA equipped with a 
binary pump (The Waters
®
 BSM HPLC pump), autosampler, 
column heater and a photo-diode array (PDA) detector. A 
Triple Quad (Waters Quattro Premier XE, USA) mass 
spectrometer equipped with an electrospray ionization (ESI) 
source was used for the mass spectrometric analysis. The 
control and treated extract powders were dissolved in 
dimethylsulfoxide to afford a 1 mg/mL stock solution. An 
aliquot of 2 µL of the stock solution was used for LC-MS 
analysis with a total run time of 25 minutes. Mass spectra 
were recorded in the positive ionization mode and with the 
full scan (m/z 50-1400). Percent change in peak height, peak 
area, and peak area% were calculated using following 
equation (1): 
%	change	in	peak	height/peak	area =


× 100  (1) 
Where, PControl and PTreated are the peak height, peak area, 
and peak area% of the control and treated samples, 
respectively. 
3. Results and Discussion 
The total ion chromatograms (TIC) of the control and 
treated samples of ashwagandha root extract are shown in 
Figure 1. The TIC of the control and treated samples 
exhibited several peaks along with their retention time (Rt) 
(Table 1 and Figure 1) indicating the presence of numerous 
phytoconstituents in the ashwagandha root extract. The 
control sample shown the 28 definite peaks in the 
chromatogram at Rt of 5.39, 5.59, 5.76, 5.95, 6.08, 6.26, 
6.39, 6.55, 6.63, 6.76, 6.88, 6.99, 7.05, 7.25, 7.29, 7.66, 
7.78, 7.92, 8.03, 8.12, 8.27, 8.48, 8.61, 8.73, 8.99, 9.10, 
9.16, and 9.30 minutes. Similarly, the treated sample 
showed 28 peaks in the chromatogram at Rt of 5.35, 5.55, 
5.79, 5.91, 6.03, 6.22, 6.35, 6.51, 6.58, 6.71, 6.84, 6.93, 
7.00, 7.19, 7.23, 7.61, 7.73, 7.87, 8.00, 8.08, 8.23, 8.44, 
8.55, 8.70, 8.96, 9.10, 9.15, and 9.29 minutes, along with 
one additional peak appeared at Rt of 5.72 minutes (Figure 
1). Each of the corresponding Rt represents the presence of 
one phytoconstituent from the ashwagandha root extract. 
The Rt of both the control and treated samples were very 
close to each other (Table 1). The peak heights/areas were 
very important for the measurement of the relative 
quantities of the compounds present in the sample. The 
height/area under the peak is directly proportional to the 
amount of each compound, which had passed the detector, 
and these areas can be calculated [41]. 
The concentration of the sample was indicated the peak 
height/area. The peak height/area% (normalization) 
calculation procedure reported the area of each peak in the 
chromatogram as a percentage of the total area of all peaks 
[44, 45]. The peak height% and peak areas% were calculated 
with the help of the following equation (2) and the results are 
presented in Table 1. 
!"#$	ℎ"&'ℎ(/)*"#%	 =
+,-./.-012	3415	64.768/9:41
;<812	3415	64.768/9:41
	=	100  (2) 
The peak height/area% did not require prior calibration 
and did not depend upon the amount of sample injected 
within the limits of the detector (normalization) [44, 45]. The 
phytoconstituents of the samples responded in the detector 
and were eluted, then peak height/area% provided the 
relative amounts of phytoconstituents (i.e. withanolides, 
alkaloids, flavonoids, etc.) present in the ashwagandha root 
extract.
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Figure 1. Total ion chromatograms (TIC) of the control and Biofield Energy Treated ashwagandha root extract using The Waters® ACQUITY UPLC. 
The peak height% of phytoconstituents present in the 
treated ashwagandha root extract was increased by 16.54%, 
4.98%, 118.12%, 99.41%, 20.53%, 3.04%, 6.09%, 38.95%, 
18.94%, 0.98%, 33.88%, 17.41%, 2.26%, and 5.23% at Rt of 
5.39, 5.59, 5.76, 5.95, 6.08, 6.26, 6.39, 6.55, 6.63, 6.76, 6.99, 
7.05, 7.92, and 8.27 minutes, respectively compared with the 
control sample (Table 1). Similarly, the peak height% of 
some of the other phytoconstituents in the treated 
ashwagandha was decreased by 8.79%, 3.39%, 3.47%, 
15.86%, 50.91%, 20.09%, 17.55%, 7.65%, 32.36%, 41.10%, 
12.24%, 2.24%, 0.48%, and 1.42% at Rt of 6.88, 7.25, 7.29, 
7.66, 7.78, 8.03, 8.12, 8.48, 8.61, 8.73, 8.99, 9.10, 9.16, and 
9.30 minutes, respectively compared with the control sample 
(Table 1). The peak height% of the phytoconstituents in the 
treated ashwagandha root extract was altered significantly in 
the range of -50.91% to 118.12% compared with the control 
sample. 
Table 1. Retention times, peak heights, peak areas, peak areas%, and percentage change in the peak areas% of both the control and Biofield Energy Treated 
samples of ashwagandha root extract. 
Withania somnifera-Control Withania somnifera-BE Treated % Change in 
PH%# 
% Change in 
PA%# Rt PH PA PH% PA% Rt PH PA PH% PA% 
5.39 71367 7917.81 1.35 1.85 5.35 61571 6251.58 1.57 2.08 16.54 12.43 
5.59 107254 7276.48 2.03 1.70 5.55 83350 7855.83 2.13 2.61 4.98 53.53 
Extra peak appeared in the BE Treated sample 5.72 42580 5170.35 1.09 1.72 NA NA 
5.76 34040 2652.73 0.64 0.62 5.79 54964 2538.87 1.40 0.84 118.12 35.48 
5.95 41399 5065.37 0.78 1.18 5.91 61113 5930.63 1.56 1.97 99.41 66.95 
6.08 49966 3680.07 0.94 0.86 6.03 44583 4071.84 1.14 1.35 20.53 56.98 
6.26 74763 7205.78 1.41 1.68 6.22 57028 4733.37 1.46 1.57 3.04 -6.55 
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Withania somnifera-Control Withania somnifera-BE Treated % Change in 
PH%# 
% Change in 
PA%# Rt PH PA PH% PA% Rt PH PA PH% PA% 
6.39 61443 4642.95 1.16 1.08 6.35 48255 3790.41 1.23 1.26 6.09 16.67 
6.55 32582 1956.15 0.62 0.46 6.51 33514 2184.83 0.86 0.73 38.95 58.70 
6.63 159434 8827.08 3.01 2.06 6.58 140387 7020.34 3.59 2.33 18.94 13.11 
6.76 186242 11816.94 3.52 2.76 6.71 139230 9008.77 3.56 3.00 0.98 8.70 
6.88 52047 3003.03 0.98 0.70 6.84 35144 1901.93 0.90 0.63 -8.79 -10.00 
6.99 44279 2315.92 0.84 0.54 6.93 43885 2583.15 1.12 0.86 33.88 59.26 
7.05 50827 3825.28 0.96 0.89 7.00 44176 3446.29 1.13 1.15 17.41 29.21 
7.25 729764 37673.13 13.80 8.80 7.19 521922 25474.71 13.33 8.47 -3.39 -3.75 
7.29 503994 42507.57 9.53 9.93 7.23 360166 29136.59 9.20 9.69 -3.47 -2.42 
7.66 56528 4892.71 1.07 1.14 7.61 35210 1931.51 0.90 0.64 -15.86 -43.86 
7.78 65181 3884.48 1.23 0.91 7.73 23689 1233.91 0.60 0.41 -50.91 -54.95 
7.92 105613 7479.50 2.00 1.75 7.87 79954 4988.71 2.04 1.66 2.26 -5.14 
8.03 191753 10425.25 3.63 2.43 8.00 113437 5939.13 2.90 1.97 -20.09 -18.93 
8.12 83596 5167.76 1.58 1.21 8.08 51025 2649.64 1.30 0.88 -17.55 -27.21 
8.27 1242286 133910.92 23.49 31.27 8.23 967773 92349.31 24.71 30.71 5.23 -1.79 
8.48 615223 59363.30 11.63 13.86 8.44 420615 38611.41 10.74 12.84 -7.65 -7.36 
8.61 203182 18234.33 3.84 4.26 8.55 101737 9287.03 2.60 3.09 -32.36 -27.47 
8.73 109056 10857.75 2.06 2.54 8.70 47554 4430.56 1.21 1.47 -41.10 -42.13 
8.99 25915 1293.78 0.49 0.30 8.96 16836 965.25 0.43 0.32 -12.24 6.67 
9.10 44063 1992.12 0.83 0.47 9.10 31890 1430.54 0.81 0.48 -2.24 2.13 
9.16 59519 3806.37 1.13 0.89 9.15 43850 2796.27 1.12 0.93 -0.48 4.49 
9.30 288226 16523.68 5.45 3.86 9.29 210349 13039.13 5.37 4.34 -1.42 12.44 
PA: Peak Area; PH: Peak Height; Rt: Retention time; NA: Not applicable; BE: Biofield Energy. 
# denotes the percentage change in the peak height% and peak 
area% of the Biofield Energy Treated sample with respect to the control sample. 
The peak area% of phytoconstituents in the treated 
ashwagandha was increased by 12.43%, 53.53%, 35.48%, 
66.95%, 56.98%, 16.67%, 58.70%, 13.11%, 8.70%, 59.26%, 
29.21%, 6.67%, 2.13%, 4.49%, and 12.44% compared with 
the control sample at Rt of 5.39, 5.59, 5.76, 5.95, 6.08, 6.39, 
6.55, 6.63, 6.76, 6.99, 7.05, 8.99, 9.10, 9.16, and 9.30 
minutes, respectively (Table 1). On the other hand, the peak 
area% of some of the phytoconstituents present in the treated 
ashwagandha was decreased by 6.55%, 10.00%, 3.75%, 
2.42%, 43.86%, 54.95%, 5.14%, 18.93%, 27.21%, 1.79%, 
7.36%, 27.47%, and 42.13% compared with the control 
sample at Rt of 6.26, 6.88, 7.25, 7.29, 7.66, 7.78, 7.92, 8.03, 
8.12, 8.27, 8.48, 8.61, and 8.73 minutes, respectively (Table 
1). The peak area% of the phytoconstituents in the treated 
ashwagandha root extract were altered in the range of -54.95 
to 66.95% compared with the control sample. An additional 
peak was appeared in the treated ashwagandha with the peak 
height% and peak area% of 1.09 and 1.72, respectively at Rt 
of 5.72 minutes, which was not detected in the control 
sample (Figure 1 and Table 1). 
The ESI-MS spectra of the control and treated 
ashwagandha root extract are shown in Figures 2 and 3, 
respectively. Some of the important possible withanolides 
were identified with the help of the ESI-MS spectral analysis 
(Table 2 and Figure 4), which were already reported in 
literature [40-43]. The possible withanolides identified both 
in control and treated samples were β-hydroxy-2,3-dihydro-
withanolide F (W1) at Rt of 7.3 minutes and m/z 489 [M + 
H]
+
 (calculated for C28H40O7, 489). Similarly, the other 
possible withanolides like withanolide A (W2), withaferine A 
(W3), withanone (W4), withanolide D (W5), 27-hydroxy 
withanolide B (W6), 5,7α-epoxy-6α,20α-dihydroxy-1-
oxowitha-2,24-dienolide (W7), 5α,17β-dihydroxy-6α,7α-
epoxy-1-oxo-witha-2,24-dienolide (W8) were identified at Rt 
of 8.6 minutes. These compounds showed the molecular ion 
peak at m/z 471 [M + H]
+
 (calcd for C28H39O6, 471) and 488 
[M + NH4]
+
 (calcd for C28H42O6N, 800) along with fragment 
ions at m/z 459 and 120 in the ESI-MS spectra of the control 
and treated samples, respectively (Figures 2 and 3). The 
withanolides like ixocarpalactone A (W9) and withanolide S 
(W10) identified at Rt of 8.7 minutes and m/z 505 [M + H]
+
 
(calculated for C28H41O8, 505). Consequently, the ESI-MS 
spectra of the control and treated samples at Rt of 9.3 minutes 
(Figure 2 and 3) revealed that withanolide sulfoxide (W11) 
(Figure 4) showed the molecular ion peak at m/z 992 [M + 
H]
+
 (calculated for C56H79O13S, 992) along with the 
fragmented ions at m/z 975, 437 and 120. Withanolide 
sulfoxide has the pharmacological properties such as 
antitumor and COX-2 enzyme inhibition activities [43]. 
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Figure 2. ESI-MS spectra of the control sample of ashwagandha root extract. 
 
Figure 3. ESI-MS spectra of Biofield Energy Treated sample of ashwagandha root extract. 
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Figure 4. Possible important withanolides (W) identified from the control and Biofield Energy Treated root extract of ashwagandha. 
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Table 2. Retention times, molecular weights, and possible withanolides 
identified in both the control and Biofield Energy Treated samples of 
ashwagandha root extract. 
Rt (min) m/z Possible Withanolide (W) 
7.3 489 β-Hydroxy-2,3-dihydro-withanolide F (W1) 
8.6 471 
Withanolide A (W2) 
Withaferine A (W3) 
Withanone (W4) 
Withanolide D (W5) 
27-Hydroxy withanolide B (W6) 
5,7α-Epoxy-6α,20α-dihydroxy-1-oxowitha-2,24-
dienolide (W7) 
5α,17β-Dihydroxy-6α,7α-epoxy-1-oxo-witha-2,24-
dienolide (W8) 
8.7 505 
Ixocarpalactone A (W9) 
Withanolide S (W10) 
9.3 992 Withanolide sulfoxide (W11) 
Rt: Retention time; W: Withanolide; Mol. Wt.: Molecular weight. 
Overall, the LC-MS analysis indicated that the peak 
height% and peak area% of most of the phytoconstituents 
present in the treated sample was significantly altered 
compared with the control sample. The Trivedi Effect
®
-
Biofield Energy Healing Treatment assumed to be having a 
significant role in the alteration of the peak height/area of the 
phytoconstituents in the ashwagandha root extract. Various 
literature reported that the Biofield Energy Treatment (The 
Trivedi Effect
®
) significantly altered the intrinsic 
physicochemical properties of many compounds, which have 
the influence on its solubility profile [28-34]. The increase in 
the solubility of a compound increase the concentration in the 
solvent system [46-48]. It can be assumed that, the relative 
peak height and peak area of the phytoconstituents in the 
Biofield Energy Treated sample was altered by altering its 
solubility profile due to the Biofield Energy Healing 
Treatment. The solubility of an analyte in the solvent system 
(diluent) has a direct effect on the peak height and peak area. 
The peak height% and peak area% are directly proportional 
to the analyte concentration [49, 50]. The Table 1 revealed 
that the Biofield Energy Treatment might have the significant 
effect on the relative amount of the phytoconstituents due to 
the Biofield Energy Healing Treatment. 
4. Conclusions 
The LC-MS analysis of the control and The Trivedi 
Effect
®
 (Energy of Consciousness) Biofield Energy Healing 
treated ashwagandha root extract showed 28 and 29 peaks, 
respectively in the chromatograms. The peak height and peak 
area were significantly altered in the treated sample 
compared with the control sample. The change in the peak 
height% of the phytoconstituents in the treated ashwagandha 
was altered significantly within the range of -50.91% to 
118.12% compared with the control sample. Similarly, the 
change in the peak area% of most of the phytoconstituents in 
the treated ashwagandha was significantly altered within the 
range of -54.95% to 66.95% compared with the control 
sample. In the treated sample, an additional peak was 
appeared at Rt of 5.72 minutes, which was not found in the 
control sample. The LC-MS spectra indicated the presence of 
possible withanolides like β-hydroxy-2, 3-dihydro-
withanolide F, withanolide A, withaferine A, withanone, 
withanolide D, ixocarpalactone A, withanolide S, 
thiowithanolide, etc. in both the samples. The peak area% 
was altered in the identified withanolides, but withanolide 
sulfoxide was increased significantly by 12.44% in the 
treated sample compared with the control sample. From the 
results, it can be hypothesized that The Trivedi Effect
®
 - 
Biofield Energy Treatment might have an impact on the 
intrinsic physicochemical properties of the phytoconstituents 
present in the ashwagandha root extract. This could be the 
probable cause of alteration in the peak height, peak area, and 
appearance of a new peak in the treated sample. As a result, 
the relative amount of the phytoconstituents assumed to be 
altered in the treated sample compared with the control 
sample. This treated ashwagandha root extract would be 
helpful for designing better pharmaceutical/nutraceutical 
formulations which might be providing a better therapeutic 
response against various diseases such as diabetes mellitus, 
allergies and septic shock; stress-related disorders like sleep 
disorder, anxiety, insomnia, depression, Attention Deficit 
Disorder (ADD), Attention Deficit Hyperactive Disorder 
(ADHD), mental restlessness (mind chattering), low libido, 
brain frog, impotency, lack of motivation, mood swings, fear 
of the future, confusion, headaches, migraines, forgetfulness, 
overwhelm, worthlessness, loneliness, indecisiveness, 
frustration, chronic fatigue, irritability, obsessive/compulsive 
behavior and panic attacks; inflammatory diseases and 
immunological disorders like Lupus, Systemic Lupus 
Erythematosus, Hashimoto Thyroiditis, Type 1 Diabetes, 
Asthma, Hepatitis, Chronic peptic ulcers, Tuberculosis, 
Chronic active hepatitis, Celiac Disease (gluten-sensitive 
enteropathy), Crohn's disease, Addison Disease, Graves’ 
Disease, Pernicious and Aplastic Anemia, Sjogren 
Syndrome, Irritable Bowel Syndrome (IBS), Multiple 
Sclerosis, Rheumatoid arthritis, Chronic periodontitis, 
Ulcerative colitis, Myasthenia Gravis, Chronic sinusitis, 
Atherosclerosis, Vasculitis, Dermatitis, Diverticulitis, 
Reactive Arthritis, Rheumatoid Arthritis, Alopecia Areata, 
Psoriasis, Scleroderma, Fibromyalgia, Chronic Fatigue 
Syndrome and Vitiligo; aging-related diseases like 
cardiovascular disease, arthritis, cancer, Alzheimer’s disease, 
dementia, cataracts, osteoporosis, diabetes, hypertension, 
glaucoma, hearing loss, Parkinson’s Disease, Huntington’s 
Disease, Spinocerebellar Ataxia, Prion Disease, Motor 
Neurone Disease, Spinal muscular atrophy, Amyotrophic 
lateral sclerosis, Friedreich’s Ataxia, Lewy Body Disease, 
chronic infections and much more. 
Abbreviations 
DMSO: dimethyl sulfoxide; EI: Electron ionization; ESI: 
Electrospray ionization; LC-MS: Liquid chromatography-
mass spectrometry; PDA: Photodiode array; Rt: Retention 
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time; UPLC: Ultra-performance liquid chromatography. 
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